Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urethral Reflectometry vs Profilometry with [S,S]-Reboxetine in SUI
NCT00141128Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of esreboxetine in stress urinary incontinence (SUI), sponsored by Pfizer. Started Dec 2005; status: completed.
02
Drugs
esreboxetine
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT00141128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141128.